FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
We report that the Forkhead family of transcription factors, FKHRL1, FKHR and AFX are novel components of neurotrophin receptor signaling. NGF rapidly induced the phosphorylation of FKHRL1 in PC12 cells. This effect is mediated by high‐affinity TrkA receptor as nerve growth factor (NGF) induced the phosphorylation of FKHRL1 only in TrkA expressing cells and not p75‐expressing cells. Additional experiments with various kinase inhibitors, the transient expression of constitutively active and dominant‐negative Akt, and in vitro kinase assay revealed that phosphatidylinositol‐3 (PtdIns3)/Akt kinase mediated the actions of NGF. Similar data were obtained for brain‐derived neurotrophic factor (BDNF), neurotrophin‐3 (NT‐3) and neurotrophin‐4 (NT‐4) in primary cortical cultured neurons. These findings demonstrate for the first time that the phosphorylation of the Forkhead family of transcription factors can be modulated by neurotrophins via Trk receptors and PtdIns3K/Akt kinase (but not MAP or S6p70 kinases) in neuronal and non‐neuronal cells. Moreover, survival assays with the PtdIns3 kinase inhibitor LY294002, active and dominant‐negative forms of Akt indicate that the phosphorylation of FKHRL1 plays a role in neurotrophins‐mediated cell survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436 · cited 2×
“…of PtdIns3K, is the cellular homolog of v-Akt and a serine/threonine protein kinase playing a key role in cell survival promoted by various factors, including NGF (Dudek et al. 1997; Philpott et al. 1997; Andjelkovic et al. 1998; Crowder and Freeman 1998; Datta et al. 1999; Mazzoni et al. 1999).”
BackgroundGlycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 2×
“For example, the activation of Akt can increase the phosphorylation of GSK3b (which potentially decreases the phosphorylation of cyclin D), Bad and caspases, as well as protein synthesis by inhibiting the interaction between 4E-BP-1 and elF-4E (Del Peso et al. 1997; Cardone et al. 1998; Diehl et al. 1998; Datta et al.…”
BackgroundNeurotrophin signal transduction in the nervous system
Kaplan, D. R., & Miller, F. D. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00092-1 · Cited by 1,944
The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth Factor
Kaplan, D. R., Hempstead, B. L., Martin-Zanca, D., Chao, M. V., & Parada, L. F. (1991) · Science · doi:10.1126/science.1850549 · Cited by 1,379
von Bartheld, C. S., Williams, R., Lefcort, F., Clary, D. O., Reichardt, L. F., & Bothwell, M. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-09-02995.1996 · Cited by 154
Cited by
FOXO transcription factors at the interface between longevity and tumor suppression
Greer, E. L., & Brunet, A. (2005) · Oncogene · doi:10.1038/sj.onc.1209086 · Cited by 1,310
Calnan, D. R., & Brunet, A. (2008) · Oncogene · doi:10.1038/onc.2008.21 · Cited by 1,170
Gilley, J., Coffer, P. J., & Ham, J. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200303026 · Cited by 645
FOXO Signaling Pathways as Therapeutic Targets in Cancer
Farhan, M., Wang, H., Gaur, U., Little, P. J., Xu, J., & Zheng, W. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.20052 · Cited by 533
Self-citationRapamycin Protects against Neuron Death in In Vitro and In Vivo Models of Parkinson's Disease
Malagelada, C., Jin, Z. H., Jackson-Lewis, V., Przedborski, S., & Greene, L. A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3944-09.2010 · Cited by 462
Metadata
- Authors
- Zheng, W., Kar, S., & Quirion, R.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2002-03-06
- Volume
- 80
- Issue
- 6
- Pages
- 1049-1061
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1973283904
- Cited by
- 89
- References
- 5
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling. https://app.cochat.ai/papers/10.1046/j.0022-3042.2002.00783.x
- The paper
- Zheng, W., Kar, S., & Quirion, R. (2002). FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling. Journal of Neurochemistry. https://doi.org/10.1046/j.0022-3042.2002.00783.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.